CN1085428A - 血防用吡喹酮涂肤纸巾 - Google Patents

血防用吡喹酮涂肤纸巾 Download PDF

Info

Publication number
CN1085428A
CN1085428A CN93111598A CN93111598A CN1085428A CN 1085428 A CN1085428 A CN 1085428A CN 93111598 A CN93111598 A CN 93111598A CN 93111598 A CN93111598 A CN 93111598A CN 1085428 A CN1085428 A CN 1085428A
Authority
CN
China
Prior art keywords
praziquantel
skin
prevention
cure
schistosomisasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN93111598A
Other languages
English (en)
Other versions
CN1048870C (zh
Inventor
宋俊生
刘学丽
严汉英
袁锡炳
徐宁宁
潘伟娜
丁洪亮
周立新
朱延勤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANJING INSTITUTE OF MATERIA MEDICA
Original Assignee
NANJING INSTITUTE OF MATERIA MEDICA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANJING INSTITUTE OF MATERIA MEDICA filed Critical NANJING INSTITUTE OF MATERIA MEDICA
Priority to CN93111598A priority Critical patent/CN1048870C/zh
Publication of CN1085428A publication Critical patent/CN1085428A/zh
Application granted granted Critical
Publication of CN1048870C publication Critical patent/CN1048870C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

血防用吡喹酮涂肤纸巾,是一种用于血防的防护 药剂。它采用含有促渗透剂二甲基亚砜的吡喹酮乙 醇水溶液配制成护肤液,使护肤液的防血吸虫尾蚴侵 袭作用能够在水中维持四小时以上,同时选择纸巾和 镀铝复合膜包装袋,制成了防疫现场实用的新剂型药 品。

Description

本发明涉及一种使用在血吸虫病疫区,特别是可涂搽在人畜皮肤表面的防护药剂。
在血吸虫病疫区使用的涂搽皮肤的药液,防止血吸虫尾蚴钻入皮肤而造成感染,是血防工作的重要研究项目。几十年来曾建立过多种筛选模型,试验了大量的配方,但都未能推广应用,这是因为它们缺乏实用于血防的护肤药剂所必须具备的几个特点,如:1.含有高效防护作用的主药;2.涂搽皮肤后能耐水冲洗的配方;3.使用方便的药剂;以及一般药品应有的安全无刺激无毒等性质。吡喹酮问世以后,因其在极低浓度下即有杀灭尾蚴的作用,解决了对高效主药的要求,也由此而产生了它的外用配方和喷涂剂型,如西德专利DE3619030.6(见对比文献一)。但在重复试验时,发现该专利的配方在配料选择和设计中未考核所成保护膜的防水冲洗性能。由于血吸虫病传染的形体为尾蚴,尾蚴生活在水中,饲机钻入人畜皮肤而使人畜受到感染,当水温在25~30℃时,尾蚴在水中最活跃,因此,疫水(含尾蚴的水)是传染媒介,耐疫水试验应在四小时以上,才能适应实际防疫的需要。我们发现,不同类型的多种配方,包括前述西德专利中的数种配方,都不能耐受一小时以上的30℃水冲洗,不适应防疫实际要求。
本发明的目的在于针对上述西德专利存在着的防水耐冲洗性能差这一主要问题,提出了一种在血吸虫病疫区使用的,可涂搽在人畜皮肤表面上的防护药剂,后者具有高效、无毒、无刺激性质,尤其是具有强渗透力,能够进入皮肤角质层下从而具有长效耐水浸泡冲洗性能。
本发明所述防疫血吸虫病的涂肤药剂,其药液由主药吡喹酮,促渗透剂二甲基亚砜,溶剂乙醇水溶液组成,吡喹酮在常温下为白色固体粉末,它在药液中的浓度为0.1~5%(W/V);二甲基亚砜在室温下为无色液体,它在药液中的浓度为0.5~20%(W/V);乙醇水溶液在常温下为无色液体,它在药液中的浓度为60~75%(W/V);余量为水。上述药液载体选用无纺布纸巾,它可最大限度地吸收药液,并贮存在纤维孔隙中,纸巾外用聚乙烯镀铝复合膜密封包装。本发明的配制,只需称取吡喹酮与二甲基亚砜,置玻璃或搪玻璃容器内,加入部分乙醇水溶液搅拌溶解,再加乙醇水溶液至所需计量,搅拌均匀,取样测定含量,合格后分装在盛有纸巾的铝塑包装袋中,电热封口,即得。使用时,拆开包装袋,取出纸巾,涂遍人畜皮肤表面与疫水可能接触的那些部位,可以在疫水中经受四小时以上的疫水冲洗。
表1        吡喹酮残留量与小鼠尾蚴感染的防护作用的关系
水流冲洗时间(小时)
0        2        4        8
药物残留量(μg)        50        5        3        0
防护率(%)        100        97.5        92.1        62.8
*在检出限度以下
注:此表处方含吡喹酮0.5g,二甲基亚砜2.0g,95%乙醇水溶液加至100ml
表2        不同配方对尾蚴的防护效果
处方号        水流冲洗时间(小时)
0        2        4
1        防护率(%)        100        97.5        92.1
2        防护率(%)        100        100        100
注:处方1号含吡喹酮0.5g,二甲基亚砜2.0g,95%乙醇加至100ml
处方2号含吡喹酮2.0g,二甲基亚砜8.0g,95%乙醇加至100ml
本发明提出了新的血防药物及包装形式,利用人畜皮肤表层作为药物贮库,选用安全、无毒、价廉、被卫生部门认可的化合物作促渗透剂,可使药物滞留在皮肤表层,防止血吸虫尾蚴钻入人畜皮肤从而使人畜受到感染,具有长效、耐水冲洗的功能,其耐疫水浸泡冲洗可达4小时以上。为了使药物方便地适用于血防现场,本发明采用纸巾剂型,它是血防用新的药物剂型,该纸巾具有最大的吸储药液能力,最小的不能被利用的药液体积比,最好的耐磨、耐拉性和柔软感,并且不含有影响药液稳定性及含量测定的添加剂。纸巾包装袋选用具有良好的抗渗透力、耐高温的镀铝复合聚乙烯膜,它可抵抗60℃二小时水浸泡,40℃一个月以上的恒温干燥和三天日光曝晒。
本发明的方案通过以下方法实施:
取吡喹酮2g,二甲基亚砜8g,加入30ml的95%乙醇水溶液,搅拌至溶解,继续加入95%乙醇水溶液至100ml,搅拌均匀,此时吡喹酮在溶液中的浓度为2%(W/V),二甲基亚砜的浓度为8%(W/V),乙醇在溶液中的浓度为70%(W/V),其余为水。
药液配成后,用无纺布纸巾吸收药液20ml,装入镀铝复合聚乙烯塑料袋,电热压封口。使用时拉开包装袋,用纸巾涂搽与疫水接触的皮肤1~2遍可防止尾有蚴感染。防护作用在水中可达四小时以上。
本药液的配方,也可以采用二甲基甲酰胺、氮酮和它们及它们与二甲基亚砜的复合配方作为促渗透剂,将主药吡喹酮贮入皮肤角质层以下,达到长效防护的目的。

Claims (3)

1、一种血防用吡喹酮涂肤纸巾,其药液由主药吡喹酮,促渗透剂二甲基亚砜,溶剂乙醇水溶液组成,吡喹酮在药液中的浓度为0.1~5%(W/V);二甲基亚砜在药液中的浓度为0.5~20%(W/V);乙醇在药液中的浓度为60~75%(W/V);余量为水。
2、根据权利要求1所述的血防用吡喹酮涂肤纸巾,它的药液载体选用无纺布纸巾,使用聚乙烯镀铝复合膜密封包装。
3、根据权利要求1所述的血防用吡喹酮涂肤纸巾,它也可以采用二甲基甲酰胺、氮酮和它们及它们与二甲基亚砜的复合配方作为促渗透剂。
CN93111598A 1993-07-30 1993-07-30 血防用吡喹酮涂肤纸巾 Expired - Fee Related CN1048870C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN93111598A CN1048870C (zh) 1993-07-30 1993-07-30 血防用吡喹酮涂肤纸巾

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN93111598A CN1048870C (zh) 1993-07-30 1993-07-30 血防用吡喹酮涂肤纸巾

Publications (2)

Publication Number Publication Date
CN1085428A true CN1085428A (zh) 1994-04-20
CN1048870C CN1048870C (zh) 2000-02-02

Family

ID=4989364

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93111598A Expired - Fee Related CN1048870C (zh) 1993-07-30 1993-07-30 血防用吡喹酮涂肤纸巾

Country Status (1)

Country Link
CN (1) CN1048870C (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102860981A (zh) * 2012-10-26 2013-01-09 天津必佳药业集团有限公司 牛羊用抗血吸虫病吡喹酮透皮溶液及其制备方法
CN104305919A (zh) * 2013-04-17 2015-01-28 惠美世界有限公司 卷筒型湿纸巾分配器

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102860981A (zh) * 2012-10-26 2013-01-09 天津必佳药业集团有限公司 牛羊用抗血吸虫病吡喹酮透皮溶液及其制备方法
CN104305919A (zh) * 2013-04-17 2015-01-28 惠美世界有限公司 卷筒型湿纸巾分配器

Also Published As

Publication number Publication date
CN1048870C (zh) 2000-02-02

Similar Documents

Publication Publication Date Title
CN1321633C (zh) 用no对指甲感染的治疗
US4264581A (en) Sunscreen composition
US20080063615A1 (en) Color changing skin sealant
KR920008026A (ko) 이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
EP0961610A1 (en) Skin preparation
WO1994026233A1 (en) Novel materials and methods utilizing a temporary visual indicator
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
EP0079556A3 (de) Morphinanderivate, ihre Herstellung, sowie diese enthaltende Arzeimittel
EP0265087A1 (en) Mosquito repellent compostions
Haft et al. Treatment of atrial arrhythmias: Effectiveness of verapamil when preceded by calcium infusion
KR940021054A (ko) 캡슐형 유비데카레논 경구 제제
EA004708B1 (ru) Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
KR960700041A (ko) 신규한 경피 흡수제제(Novel percutaneously absorbable preparation)
CN1048870C (zh) 血防用吡喹酮涂肤纸巾
Rosenberg et al. Temperature‐dependent nerve‐blocking action of lidocaine and halothane
WO1988000040A1 (en) Topical hair growing composition and kit
PT94512A (pt) Processo para a preparacao de composicoes herbicidas aperfeicoadas contendo um derivado de bipiridilio com propriedades herbicidas
Harris et al. Effects of sympathetic blockade drugs on ventricular tachycardia resulting from myocardial infarction
IE790194L (en) Pharmaceutical formulation
US11484483B2 (en) Topical lotion having sanitizing properties
JP2005296240A (ja) 清拭シート
EP0211555A2 (en) Transparent silicone compositions
US4777171A (en) Method and composition for the therapeutic and prophylactic treatment of trauma to the skin
JP5196090B2 (ja) 貼付剤
RU2000110741A (ru) Композиция парентерального введения, содержащая карбамазепин или его производные

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee